It's said 86 million Americans have high cholesterol. Here's an important heads-up for statin users in two U.S. regions.

A new investigational drug, berberine ursodeoxycholate (HTD1801), has been found to lower blood sugar, improve cholesterol ...

For decades, cholesterol-lowering medications like statins have been the go-to solution for managing heart health. However, a newer, lesser-known drug promises to dramatically lower LDL (low-density ...

A new, wide-ranging review of existing scientific data released Tuesday is pointing to the likelihood that dozens of commonly prescribed drugs could adversely affect brain development in unborn ...

A new study from Karolinska Institutet suggests that statins—medications used to lower cholesterol—may slow cognitive decline ...

according to a new ... Jan. 27, 2025 — Statins, a class of cholesterol-lowering drugs, have no effect on kidney function, a research team has ... Florescent Probes Illuminate Cholesterol and ...

The Scottish Medicines Consortium (SMC) has rejected Daiichi Sankyo’s new cholesterol-lowering drug Nilemdo for use by NHS Scotland, saying the evidence backing the drug isn’t strong enough.

A new peer-reviewed Perspective (review) article shows that many widely-used prescription medications unintentionally disrupt sterol biosynthesis, a critical process for brain development. This ...

We list the limitations and new findings from these pieces ... doctors refer to “good” and “bad” cholesterol, read this. Although GLP-1 medications have become synonymous with weight ...

"I believe that new medications and existing medications should be scrutinized for their ability to disrupt cholesterol metabolism during development," he said. "This could be done in animal models." ...

They are administered every two to four weeks, depending on LDL cholesterol response ... how generative AI is revolutionising drug development in a new podcast.